Responses
Rheumatoid arthritis
Original article
Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies
Compose a Response to This Article
Other responses
No responses have been published for this article.